Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

JOURNAL ARTICLE published May 2019 in The Lancet

Authors: Salah-Eddin Al-Batran | Nils Homann | Claudia Pauligk | Thorsten O Goetze | Johannes Meiler | Stefan Kasper | Hans-Georg Kopp | Frank Mayer | Georg Martin Haag | Kim Luley | Udo Lindig | Wolff Schmiegel | Michael Pohl | Jan Stoehlmacher | Gunnar Folprecht | Stephan Probst | Nicole Prasnikar | Wolfgang Fischbach | Rolf Mahlberg | Jörg Trojan | Michael Koenigsmann | Uwe M Martens | Peter Thuss-Patience | Matthias Egger | Andreas Block | Volker Heinemann | Gerald Illerhaus | Markus Moehler | Michael Schenk | Frank Kullmann | Dirk M Behringer | Michael Heike | Daniel Pink | Christian Teschendorf | Carmen Löhr | Helga Bernhard | Gunter Schuch | Volker Rethwisch | Ludwig Fischer von Weikersthal | Jörg T Hartmann | Michael Kneba | Severin Daum | Karsten Schulmann | Jörg Weniger | Sebastian Belle | Timo Gaiser | Fuat S Oduncu | Martina Güntner | Wael Hozaeel | Alexander Reichart | Elke Jäger | Thomas Kraus | Stefan Mönig | Wolf O Bechstein | Martin Schuler | Harald Schmalenberg | Ralf D Hofheinz